文献速递肿瘤 PET/CT

18F-氟环丁烷羧酸在原发性前列腺癌中的摄取与ASCT2及LAT1表达的相关性

Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer.
PubMed 文献 · EJNMMI Res · 2019-05-31

本研究纳入25例未接受激素治疗的原发性前列腺癌患者,术前行18F-fluciclovine PET/CT动态显像,并用组织微阵列免疫组化评估ASCT2和LAT1表达。结果发现肿瘤摄取与LAT1表达呈中度正相关(ρ=0.39,p=0.01),而与ASCT2表达无相关性;GGG>2的肿瘤摄取更高且LAT1染色更强。提示LAT1部分介导18F-fluciclovine在前列腺癌中的转运。

要点

  • 18F-fluciclovine摄取与LAT1表达呈中度正相关,与ASCT2无关。
  • GGG>2的前列腺癌摄取更高且LAT1染色更强。
  • LAT1在低级别肿瘤中表达较低甚至缺失,ASCT2则高低级别均表达。

核心结论

  • LAT1与未接受激素治疗的原发性前列腺癌中18F-fluciclovine的转运呈中度相关。
  • ASCT2在高、低Gleason级别肿瘤中均有表达,但与示踪剂摄取无关。
  • LAT1表达较不明显,部分低级别肿瘤可能缺失LAT1表达。

研究设计与样本

  • 25例组织学确诊的未接受激素治疗的前列腺癌患者,前列腺切除术前接受18F-fluciclovine PET/CT。
  • 注射368 ± 10 MBq后行动态显像,以6个连续4分钟帧的SUVmax和0-24分钟Logan图VT表示摄取。
  • 组织微阵列每处癌灶取3个芯,用免疫组化评估ASCT2和LAT1表达,两名读片者按四级视觉强度独立评分。
  • 采用Spearman秩相关系数评估ASCT2/LAT1染色强度、SUVmax/VT与Gleason分级分组的相关性。

主要发现

  • ASCT2低、中、高染色强度分别见于4个(10%)、24个(60%)、12个(30%)肿瘤。
  • LAT1无高染色强度肿瘤,中度10个(25%),低度25个(63%),阴性5个(12%)。
  • GGG>2的肿瘤18F-fluciclovine摄取显著更高且LAT1染色强度更高(p < 0.05)。
  • 18F-fluciclovine摄取与LAT1表达显著相关(2分钟SUVmax ρ=0.39,p=0.01;VT ρ=0.39,p=0.01),与ASCT2表达或GGG无相关性。

关键数值与推荐

  • 18F-fluciclovine摄取与LAT1表达:SUVmax(2分钟)ρ=0.39,p=0.01;VT ρ=0.39,p=0.01。
  • GGG>2肿瘤的18F-fluciclovine摄取和LAT1染色强度均显著更高(p < 0.05)。
  • ASCT2染色强度分布:低10%、中60%、高30%;LAT1:阴性12%、低63%、中25%、无高表达。

临床怎么用

  • 18F-fluciclovine显像用于前列腺癌局灶治疗规划时,需考虑LAT1表达异质性对摄取的影响。
  • 低级别前列腺癌可能因LAT1表达缺失而出现18F-fluciclovine摄取偏低。

局限性

  • LAT1表达在部分低级别肿瘤中可能缺失,但本研究未进一步探讨机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter1 (LAT1) in prostate cancer (PCa) and their impact on uptake of 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) which is approved for the detection of recurrent PCa. METHODS: Twenty-five hormone-naïve patients with histologically confirmed PCa underwent PET/CT before prostatectomy. Dynamic imaging was performed immediately after injection of 368 ± 10 MBq of 18F-fluciclovine and the uptake in PCa was expressed as SUVmax at six sequential 4-min time frames and as tracer distribution volume (VT) using Logan plots over 0-24 min. The expression of ASCT2 and LAT1 was studied with immunohistochemistry (IHC) on a tissue microarray (TMA) containing three cores per carcinoma lesion. The TMA slides were scored independently by two trained readers based on visual intensity of ASCT2/LAT1 expression on a four-tiered scale. The correlations between ASCT2/LAT1 staining intensity, SUVmax/VT, and Gleason grade group (GGG) were assessed using Spearman's rank correlation coefficient (ρ). RESULTS: Forty tumor foci (> 0.5 mm in diameter, max. 3 per patient) were available for TMA. In visual scoring, low, moderate, and high staining intensity of ASCT2 was observed in 4 (10%), 24 (60%), and 12 (30%) tumors, respectively. No tumors showed high LAT1 staining intensity while moderate intensity was found in 10 (25%), 25 (63%) showed low, and the remaining 5 (12%) were negative for staining with LAT1. Tumors with GGG > 2 showed significantly higher uptake of 18F-fluciclovine and higher LAT1 staining intensity (p < 0.05). The uptake of 18F-fluciclovine correlated significantly with LAT1 expression (ρ = 0.39, p = 0.01, for SUVmax at 2 min and ρ = 0.39, p = 0.01 for VT). No correlation between ASCT2 expression and 18F-fluciclovine uptake or GGG was found. CONCLUSIONS: Our findings suggest that LAT1 is moderately associated with the transport of 18F-fluciclovine in local PCa not exposed to hormonal therapy. Both high and low Gleason grade tumors express ASCT2 while LAT1 expression is less conspicuous and may be absent in some low-grade tumors. Our observations may be of importance when using 18F-fluciclovine imaging in the planning of focal therapies for PCa.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Saarinen I, Jambor I, Kim M, et al. Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer. EJNMMI Res. 2019. PMID: 31152256. doi:10.1186/s13550-019-0518-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。